Selskabets formål er at drive virksomhed med forskning og udarbejdelse af stoffer, herunder til medicinalindustrien, samt enhver i forbindelse hermed stående virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -26.1 mio. | -33 mio. | 23 mio. | 12.4 mio. | 49 | |
CVR: 36899069
Previous names: NMD Pharma ApS
Compared to 1.010 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Mahieddine El Mahdi Aïnouche joined the board
Sabine Kohar Dandiguian left the board
Anja Ulrike Harmeier joined the board
David William Evans left the board
registered with 10% ownership
registered with 33% ownership
Companies in the same industry and area
CVR 26119898
CVR 41058439
CVR 10403782
CVR 30921305
CVR 42532622
companydata.dk